Emily Lawton

Dr. Emily Lawton

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2018 in Emergency Medicine Australasia
Verified
Journal Article
Closed access
PDF file
ELEmily Lawton
Emily Lawton
HPHelen Pearce
Helen Pearce
GGGenevieve M Gabb
Genevieve M Gabb

6 January 2022 in Respirology Case Reports
Verified
Journal Article
Open access
PDF file
ELEmily Lawton
Emily Lawton
CHChien‐Li Holmes‐Liew
Chien‐Li Holmes‐Liew
Hepatopulmonary syndrome (HPS) is the triad of liver disease, hypoxia and intrapulmonary shunt. In this case report, we describe an immunocompromised female with a background of common variable immunodeficiency (CVID) who presented with haemoptysis and dyspnoea. Investigations demonstrated significant hypoxaemia and intrapulmonary right‐to‐left shunting. Further evidence revealed advanced liver cirrhosis, and a diagnosis of HPS was made. This extremely rare association of CVID and HPS is one of the few cases reported in the literature.

10 October 2024 in Respirology Case Reports
Verified
Journal Article
Open access
JSJelena Solujic
Jelena Solujic
PNPhan Nguyen
Phan Nguyen
PBPeter Bardy
Peter Bardy
YLYao Ly
Yao Ly
ELEmily Lawton
Emily Lawton
VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, and somatic) syndrome is a rare multisystem disease affecting predominantly males over 50 and manifesting as widespread progressive inflammatory sequelae and haematological dysfunction. We describe a patient who presented with systemic symptoms of fevers, night sweats and weight loss, and developed progressive inflammatory sequelae including cutaneous lesions, haematological dysfunction, lymphadenopathy, migratory inflammatory arthropathies, with new pulmonary infiltrates, following infection with Epstein Barr Virus. Laboratory investigations, bronchoscopy, bone marrow biopsy and imaging were consistent with an inflammatory aetiology. The constellation of organ system involvement, laboratory, biopsy, and imaging results were suspicious for VEXAS syndrome, and this diagnosis was confirmed by identification of a somatic mutation in the UBA1 gene following extensive exclusion of infectious and autoimmune causes. Interestingly the onset of the VEXAS syndrome coincided with serological confirmation of Epstein Barr Virus raising the importance of further exploration into the underlying aetiology of VEXAS syndrome.

Verified
Journal Article
Open access
PDF file
JCJames M Cooper
James M Cooper
SCShiye Chen
Shiye Chen
SLSusan E. Lester
Susan E. Lester
JKJulia(Joo Yeon) Kim
Julia(Joo Yeon) Kim
JGjason Gummow
jason Gummow
EREugene Roscioli
Eugene Roscioli
Assessing autophagy may offer insights into the pathogenesis of chronic obstructive pulmonary disease (COPD). However, measuring the dynamic aspect of autophagy is challenging, and sample manipulation can cause signal fluctuations that deviate from physiological conditions. We applied an organotypic method to quantify autophagy in COPD, where it frequently demonstrates disease-related dysregulation. Blood from control and COPD participants was treated with or without chloroquine. Microtubule-associated protein 1 light chain 3B II (LC3B-II) abundance was quantified in peripheral blood mononuclear cells (PBMCs), and findings were validated by transmission electron microscopy. Our observations show that while basal LC3B-II abundance was similar between groups (p = 0.60), autophagic flux was significantly lower in the COPD cohort, suggesting disruption in the regulatory factors that direct autophagosome clearance (p = 0.004). This was supported by less frequent observations of autophagy-related vacuoles in the cytosol of COPD-derived PBMCs. Our findings indicate that the suppression of autophagy can be detected in the blood of individuals with COPD, which warrants further investigation into its contribution to extrapulmonary disease processes.

14 September 2024 in European Respiratory Journal
Verified
Conference Paper
Closed access
ELEmily Lawton
Emily Lawton
PNPhan Nguyen
Phan Nguyen
MYMary Young
Mary Young
NJNicole Jones
Nicole Jones
PRPaul Reynolds
Paul Reynolds
Aim: Increased demand for inpatient and Emergency Department (ED) healthcare, hospital congestion, and increased urgent referrals requires adaptive healthcare practises. We designed and implemented a Respiratory Rapid Access Service (RRAS) offering respiratory patients a safe, alternative urgent pathway. Methods: RRAS was implemented as a part-time pilot service. Approved pathways included direct patient contact, specialty or ED referral and expedited urgent referral review, including symptomatic malignancy. Respiratory physician review occurred within 24-72hrs in a specialist clinic. Data captured included patient demographics, medical activity, ED presentations avoided, hospital admissions prevented and qualitative patient evaluation. Results: In 10-months 393 patients were reviewed: 681 separate episodes of care. Commonest respiratory pathology was malignancy, pleural, and airways disease. RRAS prevented 359 ED presentations, saving 2129 ED hours. 181 hospital admissions avoided, and 115 early discharges facilitated, equating to 957 bed days saved. 300 urgent referrals, 115 interventional procedures and 77 MDM discussions expedited.100% patients who used RRAS deemed it an appropriate alternative to ED and 100% felt comfortable using RRAS again. Conclusion: The RRAS pilot successfully demonstrated prevention of ambulance calls, ED presentations, and hospital admissions with reduced inpatient separations and average length of stay. Expedited reviews optimised delivery of urgent care, and reduced cancer time to diagnosis via streamlined diagnostics. We will expand to full-time, offering increased urgent respiratory medical and nursing reviews, ultimately streamlining future healthcare delivery.